Associated Papers
Target therapy for BRAF mutated anaplastic thyroid cancer: a clinical and molecular study.
da Silva TN et al.
European Journal of Endocrinology, 2023
Activating mutations in CSF1R and additional receptor tyrosine kinases in histiocytic neoplasms.
Durham BH et al.
Nature Medicine, 2019
31768065 (PubMed )
Supplement: NIHMS1541330-supplement-1.pdf
Rosai-Dorfman Disease Harboring an Activating KRAS K117N Missense Mutation.
Shanmugam V et al.
Head and Neck Pathology, 2016
Select a paper to view details